Search: onr:"swepub:oai:DiVA.org:liu-188452" >
Effect of N-3 Polyu...
Effect of N-3 Polyunsaturated Fatty Acids on Lipid Composition in Familial Hypercholesterolemia : A Randomized Crossover Trial
-
- Hande, Liv Nesse (author)
- Nordland Hosp, Norway; UiT Arctic Univ Norway, Norway
-
- Kjellmo, Christian (author)
- Nordland Hosp, Norway; UiT Arctic Univ Norway, Norway
-
- Pettersen, Kristin (author)
- Nordland Hosp, Norway
-
show more...
-
- Ljunggren, Stefan (author)
- Linköpings universitet,Avdelningen för prevention, rehabilitering och nära vård,Medicinska fakulteten,Region Östergötland, Arbets- och miljömedicin
-
- Karlsson, Helen (author)
- Linköpings universitet,Avdelningen för prevention, rehabilitering och nära vård,Medicinska fakulteten,Region Östergötland, Arbets- och miljömedicin
-
- Cederbrant, Karin (author)
- Linköpings universitet,Avdelningen för inflammation och infektion,Medicinska fakulteten
-
- Marcusson-Ståhl, Maritha (author)
- Swedish Toxicol Sci Res Ctr, Sweden
-
- Hovland, Anders (author)
- Nordland Hosp, Norway; UiT Arctic Univ Norway, Norway
-
- Lappegard, Knut Tore (author)
- Nordland Hosp, Norway; UiT Arctic Univ Norway, Norway
-
show less...
-
(creator_code:org_t)
- 2022-07-27
- 2022
- English.
-
In: Biomedicines. - : MDPI. - 2227-9059. ; 10:8
- Related links:
-
https://liu.diva-por... (primary) (Raw object)
-
show more...
-
https://urn.kb.se/re...
-
https://doi.org/10.3...
-
show less...
Abstract
Subject headings
Close
- Individuals with familial hypercholesterolemia (FH) have an increased risk of cardiovascular disease. Treatment is mainly low-density lipoprotein cholesterol (LDL-C) reduction. How omega-3 polyunsaturated fatty acids (n-3 PUFAs) supplements affect lipoproteins in FH subjects is unknown. We hypothesized that a high-dose n-3 PUFA supplement would reduce atherogenic lipoproteins and influence the high-density lipoprotein cholesterol (HDL-C) function. We performed a randomized, double-blinded crossover study with 34 genetically verified FH individuals (18-75 years, clinically stable, statin treatment > 12 months). Treatment was 4 g n-3 PUFAs (1840 mg eicosapentaenoic acid and 1520 mg docosahexaenoic acid daily) or four capsules of olive oil for three months in a crossover design with a washout period of three months. The defined outcomes were changes in triglycerides, lipoproteins, lipoprotein subfractions, apolipoproteins, and HDL-C function. After treatment with n-3 PUFAs, total cholesterol, LDL-C, and triglycerides were reduced compared to placebo (p <= 0.01 for all). Total HDL-C levels were unchanged, but the subfraction of large HDL-C was higher (p <= 0.0001) after n-3 PUFAs than after placebo, and intermediate HDL-C and small HDL-C were reduced after n-3 PUFAs compared to placebo (p = 0.02 and p <= 0.001, respectively). No changes were found in apolipoproteins and HDL-C function. N-3 PUFAs supplements reduced atherogenic lipoproteins in FH subjects, leaving HDL-C function unaffected.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Endokrinologi och diabetes (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Endocrinology and Diabetes (hsv//eng)
Keyword
- familial hypercholesterolemia; omega-3 fatty acids; lipids; cardiovascular disease; randomized trial
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
To the university's database